Patents matching “vaccination”

US 9579370

Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination

The Board of Regents of the University of Texas System · Granted Feb 28, 2017 · Expires Feb 23, 2037

US 9556244

Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9408896

Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted Aug 9, 2016 · Expires Aug 4, 2036

US 8741313

Polypeptide vaccine and vaccination strategy against mycobacterium

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

US 8722063

Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted May 13, 2014 · Expires May 8, 2034

US 8703150

Methods of using Bacillus anthracis protective antigen sequences for vaccination

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

US 8435533

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

The Board of Regents of the University of Texas System · Granted May 7, 2013 · Expires May 2, 2033

US 8420072

Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Apr 16, 2013 · Expires Apr 11, 2033

US 8298542

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

The Board of Regents of the University of Texas System · Granted Oct 30, 2012 · Expires Oct 25, 2032

US 8206724

Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia

The Board of Regents of the University of Texas System · Granted Jun 26, 2012 · Expires Jun 21, 2032

US 8153116

Use of conditional plasmodium strains lacking an essential gene in malaria vaccination

UNIVERSITY OF CONNECTICUT · Granted Apr 10, 2012 · Expires Apr 5, 2032

US 8128921

Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination

UNIVERSITY OF CONNECTICUT · Granted Mar 6, 2012 · Expires Mar 1, 2032

US 8017130

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 13, 2011 · Expires Sep 8, 2031

US 7811592

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

The Board of Regents of the University of Texas System · Granted Oct 12, 2010 · Expires Oct 7, 2030

US 7736652

Antibody fusion proteins: effective adjuvants of protein vaccination

The Regents of the University of California · Granted Jun 15, 2010 · Expires Jun 10, 2030

US 7655241

Methods and compositions for vaccination against or involving enterobacteriaceae bacteria

The Board of Regents of the University of Texas System · Granted Feb 2, 2010 · Expires Jan 28, 2030

US 7635485

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 22, 2009 · Expires Dec 17, 2029

US 7608272

Methods and compositions for vaccination of animals with PRRSV antigens with improved immunogenicity

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 27, 2009 · Expires Oct 22, 2029

US 7288258

Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination

Peptide Immune Ligands · Granted Oct 30, 2007 · Expires Oct 25, 2027

US 7148323

Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 12, 2006 · Expires Dec 7, 2026

US 6930176

Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 16, 2005 · Expires Aug 11, 2025